ConductScience.org, home

Paper40796643

LRRK2-mutant microglia and neuromelanin synergize to drive dopaminergic neurodegeneration in an iPSC-based Parkinson's disease model.

Blasco-Agell L and 19 others. Commun Biol, 2025. Cited by 12 papers, by iCite.

Cite this record

ConductScience Library. LRRK2-mutant microglia and neuromelanin synergize to drive dopaminergic neurodegeneration in an iPSC-based Parkinson's disease model. Papers, record 40796643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40796643

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
LRRK2-mutant microglia and neuromelanin synergize to drive dopaminergic neurodegeneration in an iPSC-based Parkinson's disease model.
PubMed
Journal
Commun Biol
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
3.22, provisional
iCite
Revised in PubMed
2025-08-26
PubMed

Authors20

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Blasco-Agell LLucas
2Pons-Espinal MMeritxellhttps://orcid.org/0000-0003-0832-2963
3Testa VVeronicahttps://orcid.org/0000-0001-9041-7325
4Roch GGerardhttps://orcid.org/0000-0002-9045-0579
5Montero-Muñoz JJarahttps://orcid.org/0000-0002-6877-4833
6Fernandez-Carasa IIrenehttps://orcid.org/0000-0002-8195-3510
7Baruffi VValentina
8Gonzalez-Sepulveda MMartahttps://orcid.org/0000-0002-5627-847X
9Richaud-Patin YYvonne
10Jimenez SSenda
11Cuadros TThaishttps://orcid.org/0000-0001-7376-7470
12Cladera-Sastre JMJoana M
13Compte JJoanhttps://orcid.org/0000-0001-5447-5122
14Manglano-Artuñedo ZZoe
15Ventura SSalvadorhttps://orcid.org/0000-0002-9652-6351
16Juan MManelhttps://orcid.org/0000-0002-3064-1648
17Tolosa EEduardo
18Raya AAngelhttps://orcid.org/0000-0003-2189-9775
19Vila MMiquelhttps://orcid.org/0000-0002-1352-989X
20Consiglio AAntonellahttps://orcid.org/0000-0002-3988-6254

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2Major topic
Induced Pluripotent Stem CellsMajor topic
MelaninsMajor topic
Parkinson DiseaseMajor topic
MicrogliaMajor topic
Dopaminergic NeuronsMajor topic
MutationMajor topic
Humans

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
PID2019-108792GB-I00Ministry of Economy and Competitiveness | Agencia Estatal de Investigación (Spanish Agencia Estatal de Investigación)PubMed
PID2022-137963OB-I00Ministry of Economy and Competitiveness | Agencia Estatal de Investigación (Spanish Agencia Estatal de Investigación)PubMed
202012-32Fundació la Marató de TV3 (TV3 Marathon Foundation)PubMed

Source PubMed

Download CSV of grants

References75

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126365310LRRK2 G2019S mutation attenuates microglial motility by inhibiting focal adhesion kinase.Nat Commun2015https://conductscience.org/library/papers/26365310PubMed
22575832Selective vulnerability of pigmented dopaminergic neurons in Parkinson's disease.Acta Neurol Scand Suppl1989https://conductscience.org/library/papers/2575832PubMed
319214748Interleukin-6 serum levels in patients with Parkinson's disease.Neurochem Res2009https://conductscience.org/library/papers/19214748PubMed
420921534LRRK2 is involved in the IFN-gamma response and host response to pathogens.J Immunol2010https://conductscience.org/library/papers/20921534PubMed
516219675A possible role for humoral immunity in the pathogenesis of Parkinson's disease.Brain2005https://conductscience.org/library/papers/16219675PubMed
628780180Neuropathology of Parkinson disease.Parkinsonism Relat Disord2018https://conductscience.org/library/papers/28780180PubMed
711205147Changes in cytokines and neurotrophins in Parkinson's disease.J Neural Transm Suppl2000https://conductscience.org/library/papers/11205147PubMed
819252484Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling.Nat Biotechnol2009https://conductscience.org/library/papers/19252484PubMed
919732964Increased serum levels of soluble tumor necrosis factor-alpha receptor-1 in patients with Parkinson's disease.J Neuroimmunol2009https://conductscience.org/library/papers/19732964PubMed
1028649611LRRK2 levels in immune cells are increased in Parkinson's disease.NPJ Parkinsons Dis2017https://conductscience.org/library/papers/28649611PubMed
1123573196Robust and highly-efficient differentiation of functional monocytic cells from human pluripotent stem cells under serum- and feeder cell-free conditions.PLoS One2013https://conductscience.org/library/papers/23573196PubMed
1219487152[11C]-PK11195 PET: quantification of neuroinflammation and a monitor of anti-inflammatory treatment in Parkinson's disease?Parkinsonism Relat Disord2010https://conductscience.org/library/papers/19487152PubMed
1319957214Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson's disease.Neurotox Res2011https://conductscience.org/library/papers/19957214PubMed
141494900Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content?J Neurochem1992https://conductscience.org/library/papers/1494900PubMed
1529800472Mutant LRRK2 mediates peripheral and central immune responses leading to neurodegeneration in vivo.Brain2018https://conductscience.org/library/papers/29800472PubMed
1628257086High-Throughput Screening Methodology to Identify Alpha-Synuclein Aggregation Inhibitors.Int J Mol Sci2017https://conductscience.org/library/papers/28257086PubMed
1728489815Common genetic variation drives molecular heterogeneity in human iPSCs.Nature2017https://conductscience.org/library/papers/28489815PubMed
1821778362Synaptic pruning by microglia is necessary for normal brain development.Science2011https://conductscience.org/library/papers/21778362PubMed
1931251435Neuromelanin, aging, and neuronal vulnerability in Parkinson's disease.Mov Disord2019https://conductscience.org/library/papers/31251435PubMed
2029443098A Novel In Vitro Live-imaging Assay of Astrocyte-mediated Phagocytosis Using pH Indicator-conjugated Synaptosomes.J Vis Exp2018https://conductscience.org/library/papers/29443098PubMed

See all 75 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
42726290Molecular programs in human locus coeruleus link APOE and neuromelanin to Alzheimer's vulnerability.Acta Neuropathol2026https://conductscience.org/library/papers/42726290PubMed
42140967α-Synuclein aggregates induce mitochondrial damage and trigger innate immunity to drive neuron-microglia communication.Nat Commun2026https://conductscience.org/library/papers/42140967PubMed
42101666Using iPSC models to examine neuron-glia interactions in neurodegenerative diseases.Biosci Rep2026https://conductscience.org/library/papers/42101666PubMed
41851867Inflammatory signaling differentially changes chromatin accessibility and gene expression of the PD- associated kinase LRRK2 between human and mice.Mol Neurodegener2026https://conductscience.org/library/papers/41851867PubMed
41820341Impaired α -Synuclein aggregate clearance in neuronal cells drive their spread to microglia through tunneling nanotubes.Nat Commun2026https://conductscience.org/library/papers/41820341PubMed
41648127Inflammatory signaling differentially changes chromatin accessibility and gene expression of the PD- associated kinase LRRK2 between human and mice.bioRxiv2026https://conductscience.org/library/papers/41648127PubMed
41465422Glial Cells in the Early Stages of Neurodegeneration: Pathogenesis and Therapeutic Targets.Int J Mol Sci2025https://conductscience.org/library/papers/41465422PubMed
41460324Revisiting the alpha-synuclein paradox in melanoma-Parkinson's disease connection: more than a tale of two cell fates.Cell Mol Life Sci2025https://conductscience.org/library/papers/41460324PubMed
41278831Impact of Alzheimer's disease risk factors and local neuromelanin content on the transcriptomic landscape of the human locus coeruleus.bioRxiv2025https://conductscience.org/library/papers/41278831PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
GNE10020PubTator's text mininghttps://conductscience.org/library/genes/10020NCBI Gene
LRRK2120892PubTator's text mininghttps://conductscience.org/library/genes/120892NCBI Gene
SNCA6622PubTator's text mininghttps://conductscience.org/library/genes/6622NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40796643

GET https://conductscience.org/api/papers/v1/40796643/references?page=2